Preterm labor, preterm premature rupture of membranes, and chorioamnionitis

Edward R Newton1

  • 1Department of Obstetrics and Gynecology, Brody School of Medicine, East Carolina University, Teaching Annex, Pitt County Memorial Hospital, Greenville, NC 27834, USA. newtoned@mail.ecu.edu

Insights

This review examines the link between infection and preterm birth, exploring management strategies like antibiotic therapy to reduce risks. It also discusses potential neurodevelopmental handicaps linked to intra-amniotic infections.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Neonatal Health

Background:

  • Preterm birth remains a significant global health challenge with multifactorial causes.
  • Infection is a recognized contributor to preterm birth, necessitating a deeper understanding of its mechanisms.
  • Intra-amniotic infection (IAI) is a critical concern in preterm labor.

Purpose of the Study:

  • To review the etiology and biochemical pathways linking infection to preterm birth.
  • To discuss the management of infection-related risks for preventing preterm birth.
  • To evaluate the potential neurodevelopmental consequences of intra-amniotic infection.

Main Methods:

  • Literature review of current research on infection and preterm birth.
  • Analysis of biochemical links and etiological factors.
  • Synthesis of evidence on prophylactic and therapeutic antibiotic strategies.

Main Results:

  • Infection plays a key role in the pathophysiology of preterm birth.
  • Antibiotic therapy shows potential in preventing and managing infection-related preterm birth.
  • Intra-amniotic infection is associated with increased risks of adverse neonatal outcomes, including neurodevelopmental handicap.

Conclusions:

  • Effective management of infections is crucial for reducing preterm birth rates.
  • Targeted antibiotic interventions may mitigate risks associated with preterm labor and IAI.
  • Further research is needed to fully elucidate the neurodevelopmental impact of IAI.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...